SCHEMBL4333437

SCHEMBL4333437

CCCCOc1ccc(COC(=O)Nc2ccc(OC)c(CC(OC(C)C)C(=O)O)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 7/20 0.41
PPARG P37231 2/20 0.41
PPARD Q03181 2/20 0.41
PPARA Q07869 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPT P10636 2/20 0.38
TP53 P04637 1/20 0.38
EGFR P00533 1/20 0.38
KDR P35968 1/20 0.38
C5 P01031 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4333142 0.96 SMN1; SMN2 (0.40) FAAHPPARGPPARDPPARASMN1; SMN2
SCHEMBL4343697 0.93 GAA (0.44) PPARGPPARDPPARASMN1; SMN2KMT2A
SCHEMBL13810706 0.89 SMN1; SMN2 (0.43) SMN1; SMN2KMT2AMEN1GAANPC1
SCHEMBL4335887 0.89 SMN1; SMN2 (0.44) PPARASMN1; SMN2KMT2AMEN1GAA
SCHEMBL4337108 0.86 PPARA (0.45) PPARGPPARDPPARASMN1; SMN2KMT2A
SCHEMBL4332360 0.85 PPARG (0.42) FAAHPPARGPPARDPPARAITGB3
SCHEMBL4343465 0.84 SMN1; SMN2 (0.45) SMN1; SMN2KMT2AMEN1NPC1RAB9A
SCHEMBL4338949 0.84 PPARA (0.49) PPARGPPARDPPARASMN1; SMN2KMT2A
SCHEMBL13810699 0.84 ALDH1A1 (0.43) PPARGSMN1; SMN2KMT2AMEN1GAA
SCHEMBL4340787 0.83 NPC1 (0.47) SMN1; SMN2KMT2ANPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 FAAH 2839/4885PPARG 379/4885PPARD 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.